Fundamental dimension Equity attribute | ANMPLeader $0.40▲+0.00% Cap $1.48MP/E 1.9x QuantScore63/100 | ADHCPeer $0.0005▲+6.38% Cap $1.20MP/E -2.5x QuantScore18/100 | ENEVFPeer $0.0065▼-18.75% Cap $2.23MP/E -11.4x QuantScore32/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
31/100 |
52/100 |
76/100 |
Valuation Multiples, PEG & DCF upside | 100/100 | 0/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 71/100 | 20/100 | 20/100 |
Growth Revenue / earnings growth & margins | 52/100 | 0/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 1.9x | -2.5x | -11.4x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -1.4x | -1.3x | -8.8x |
Price / Sales | 0.4x | — | — |
Price / Free Cash Flow | 2.7x | — | -11.1x |
PEG ratio | 0.01 | -0.05 | 0.05 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 2 / 9 | 2 / 9 |
Altman Z-Score | -18.56 (Distress) | -601.28 (Distress) | -310.38 (Distress) |
Total debt / equity | 0.00 | -0.07 | -0.17 |
Quick ratio | 53.0x | 0.0x | 0.6x |
Interest coverage | — | -635.8x | -46.1x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +18.6% | — | — |
Net income growth YoY | +228.8% | -38.5% | -103.4% |
Gross margin (TTM) | 47.6% | 0.0% | 0.0% |
Operating margin (FY) | 19.5% | — | — |
FCF margin (FY) | 14.1% | — | — |
5. Trailing price performancePrice change over period |
1M return | 0.0% | +25.0% | +4.0% |
3M return | 0.0% | +25.0% | +26.5% |
6M return | 0.0% | -16.7% | -19.1% |
Year to date | 0.0% | -16.7% | +14.0% |
1Y return | 0.0% | -77.8% | +33.3% |
3Y return | 0.0% | -62.7% | -39.3% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.8992 +124.8% upside | $-0.0019 -482.8% premium | $0.0003 -95.5% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |